WADA decides that weight-loss drugs will not be added to its 2027 Prohibited List, meaning athletes are not banned from using them. However, the substances remain subject to monitoring, according to reporting from multiple outlets.
The decision reflects WADA’s approach to risk management rather than an outright restriction. BBC News and Yahoo Sports describe the drugs as staying on a monitoring list, while The Independent adds that WADA will revisit its position at next year’s executive committee meeting. That process indicates WADA could reassess whether the monitored substances should later be considered for prohibition.
Across the sources, there is agreement on the core outcome: no ban for 2027, continued monitoring, and a future review planned through WADA’s governance timeline.
